Biotech · Private company

InSightec

Track this companyFree. Adds InSightec to your Dealase workspace and tells you when its record changes.

Clinical trials2518 recruiting or active

Pipeline programs26From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline26

AtezolizumabPhase 3 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
Blood Brain Barrier Opening - OncologyPhase 3 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
CemiplimabPhase 3 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
IptilimumabPhase 3 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
NivolumabPhase 3 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
PembrolizumabPhase 3 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
CarboplatinPhase 2 · Recurrent GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
DoxorubicinPhase 2 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
ExablatePhase 2 · Brain TumorClinicalTrials.gov · fetched Nov 12, 2026
Exablate BBBDPhase 2 · Recurrent GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
Blood Brain Barrier (BBB) DisruptionAlzheimer DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Body System - FunctionalUterine FibroidClinicalTrials.gov · fetched Nov 12, 2026
Exablate 4000Parkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
ExAblate 4000 SystemBenign Centrally-Located Intracranial TumorsClinicalTrials.gov · fetched Nov 12, 2026
Exablate BBBDGliomaClinicalTrials.gov · fetched Nov 12, 2026
Exablate Model 4000 Type 1.0/1.1Essential TremorClinicalTrials.gov · fetched Nov 12, 2026
Exablate Model 4000 Type 2.0/2.1Opioid-use DisorderClinicalTrials.gov · fetched Nov 12, 2026
ExAblate PallidotomyParkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Exablate Pallidotomy, UnilateralMovement DisordersClinicalTrials.gov · fetched Nov 12, 2026
Exablate Prostate TreatmentProstate CancerClinicalTrials.gov · fetched Nov 12, 2026
ExAblate transcranial systemBrain TumorClinicalTrials.gov · fetched Nov 12, 2026
ExAblate Transcranial SystemParkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Focused Ultrasound (Exablate Model 4000)GlioblastomaClinicalTrials.gov · fetched Nov 12, 2026
Focused ultrasound (FUS)GliomaClinicalTrials.gov · fetched Nov 12, 2026
Sham ExAblate PallidotomyParkinson DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Unilateral thalamotomyTremor Associated With Tremor Dominant Parkinson's DiseaseClinicalTrials.gov · fetched Nov 12, 2026

Clinical trials25

High-Intensity Focused Ultrasonic Ablation of the Centromedian Thalamic Nucleus for Treatment of Medically Refractory Generalized Epilepsy in Patients Ages 18 Years to 89 YearsNA · NOT_YET_RECRUITING · started Feb 1, 2027ClinicalTrials.gov NCT07803692 · fetched Nov 12, 2026
Safety and Effectiveness of Blood-Brain Barrier Disruption (BBBD) in Subjects With Suspected Infiltrating GliomaNA · WITHDRAWN · started Oct 23, 2024ClinicalTrials.gov NCT04667715 · fetched Nov 12, 2026
MRgFUS Pallidotomy for the Treatment of Task Specific Focal Hand Dystonia (TSFD)NA · RECRUITING · started Jun 10, 2024ClinicalTrials.gov NCT06367608 · fetched Nov 12, 2026
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD)NA · COMPLETED · started Sep 19, 2023ClinicalTrials.gov NCT06612788 · fetched Nov 12, 2026
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor ComplicationsRECRUITING · started Jan 23, 2023ClinicalTrials.gov NCT05539196 · fetched Nov 12, 2026
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)PHASE1_PHASE2 · ACTIVE_NOT_RECRUITING · started Jan 4, 2023ClinicalTrials.gov NCT05630209 · fetched Nov 12, 2026
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain MetsPHASE3 · RECRUITING · started Aug 12, 2022ClinicalTrials.gov NCT05317858 · fetched Nov 12, 2026
Blood-Brain Barrier Disruption (BBBD) for Liquid Biopsy in Subjects With GlioBlastoma Brain TumorsNA · COMPLETED · started Aug 8, 2022ClinicalTrials.gov NCT05383872 · fetched Nov 12, 2026
Safety and Feasibility of Exablate Blood-Brain Barrier Disruption for Mild Cognitive Impairment or Mild Alzheimer's Disease Undergoing Standard of Care Monoclonal Antibody (mAb) TherapyEARLY_PHASE1 · ACTIVE_NOT_RECRUITING · started Jul 14, 2022ClinicalTrials.gov NCT05469009 · fetched Nov 12, 2026
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's DiseaseRECRUITING · started Apr 28, 2022ClinicalTrials.gov NCT04991831 · fetched Nov 12, 2026
MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal NeuralgiaNA · ACTIVE_NOT_RECRUITING · started Aug 16, 2021ClinicalTrials.gov NCT04579692 · fetched Nov 12, 2026
Evaluation of the Safety and Effectiveness of Bilateral Exablate Ablation of the Pallidothalamic Tract (PTT) for the Treatment of the Motor Complications of Parkinson's Disease (PD)NA · ACTIVE_NOT_RECRUITING · started May 14, 2021ClinicalTrials.gov NCT04728295 · fetched Nov 12, 2026
Study of Sonodynamic Therapy in Participants With Recurrent High-Grade GliomaEARLY_PHASE1 · TERMINATED · started Mar 15, 2021ClinicalTrials.gov NCT04559685 · fetched Nov 12, 2026
Exablate Blood-Brain Barrier Disruption for the Treatment of rGBM in Subjects Undergoing Carboplatin MonotherapyPHASE1_PHASE2 · COMPLETED · started Nov 6, 2020ClinicalTrials.gov NCT04417088 · fetched Nov 12, 2026
Bilateral Treatment of Medication Refractory Essential TremorNA · ACTIVE_NOT_RECRUITING · started Jun 30, 2020ClinicalTrials.gov NCT04112381 · fetched Nov 12, 2026
Continued Access of Focal MR-Guided Focused Ultrasound for Localized Intermediate Risk Prostate LesionsNA · ACTIVE_NOT_RECRUITING · started Dec 19, 2019ClinicalTrials.gov NCT03998657 · fetched Nov 12, 2026
Exablate for LIFU Neuromodulation in Patients With Opioid Use Disorder (OUD) and/or Other Substance Use Disorders (SUDs)NA · RECRUITING · started Nov 27, 2019ClinicalTrials.gov NCT04197921 · fetched Nov 12, 2026
Assessment of Safety and Feasibility of ExAblate Blood-Brain Barrier (BBB) DisruptionNA · COMPLETED · started Mar 26, 2019ClinicalTrials.gov NCT03551249 · fetched Nov 12, 2026
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's DiseaseNA · RECRUITING · started Sep 28, 2018ClinicalTrials.gov NCT03671889 · fetched Nov 12, 2026
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's DiseaseNA · ACTIVE_NOT_RECRUITING · started Feb 9, 2018ClinicalTrials.gov NCT03319485 · fetched Nov 12, 2026
A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult SubjectsNA · RECRUITING · started Feb 28, 2017ClinicalTrials.gov NCT03028246 · fetched Nov 12, 2026
Global Registry: ExAblate Neuro MR Guided Focused Ultrasound (MRgFUS) of Neurological Disorders:ACTIVE_NOT_RECRUITING · started Dec 1, 2016ClinicalTrials.gov NCT03100474 · fetched Nov 12, 2026
Post-Exablate Pregnancy Outcomes Registry Study: Exablate Treatment of Symptomatic Uterine FibroidsRECRUITING · started Feb 16, 2016ClinicalTrials.gov NCT05386615 · fetched Nov 12, 2026
ExAblate Transcranial MRgFUS of the Subthalamic Nucleus for Treatment of Parkinson's DiseaseNA · COMPLETED · started Sep 1, 2014ClinicalTrials.gov NCT02246374 · fetched Nov 12, 2026
MRI-Guided Focused Ultrasound Feasibility Study for Brain TumorsNA · ACTIVE_NOT_RECRUITING · started Aug 1, 2012ClinicalTrials.gov NCT00147056 · fetched Nov 12, 2026